AR090052A1 - Compuestos para la prevencion o tratamiento de la mucositis oral - Google Patents

Compuestos para la prevencion o tratamiento de la mucositis oral

Info

Publication number
AR090052A1
AR090052A1 ARP130100106A ARP130100106A AR090052A1 AR 090052 A1 AR090052 A1 AR 090052A1 AR P130100106 A ARP130100106 A AR P130100106A AR P130100106 A ARP130100106 A AR P130100106A AR 090052 A1 AR090052 A1 AR 090052A1
Authority
AR
Argentina
Prior art keywords
prevention
treatment
oral mucositis
compounds
diastereoisomer
Prior art date
Application number
ARP130100106A
Other languages
English (en)
Inventor
Sharma Somesh
Hatfield Alan
Acharya Shivani
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of AR090052A1 publication Critical patent/AR090052A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto de la fórmula (1) en donde Ar es un grupo fenilo, que está no sustituido o sustituido por 1, 2, ó 3 sustituyentes idénticos o diferentes seleccionados de: halógeno, nitro, ciano, alquilo C₁₋₄, trifluorometilo, hidroxilo y alcoxi C₁₋₄; o una sal, un solvato, un estereoisómero o un diastereoisómero farmacéuticamente aceptable de los mismos, para uso en la prevención, tratamiento o reducción de la gravedad de la mucositis oral en un sujeto que experimente terapia cancerígena.
ARP130100106A 2012-01-13 2013-01-14 Compuestos para la prevencion o tratamiento de la mucositis oral AR090052A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261586428P 2012-01-13 2012-01-13

Publications (1)

Publication Number Publication Date
AR090052A1 true AR090052A1 (es) 2014-10-15

Family

ID=47748672

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100106A AR090052A1 (es) 2012-01-13 2013-01-14 Compuestos para la prevencion o tratamiento de la mucositis oral

Country Status (6)

Country Link
US (2) US20140348950A1 (es)
EP (1) EP2802323B1 (es)
AR (1) AR090052A1 (es)
IN (1) IN2014MN01546A (es)
TW (1) TW201338774A (es)
WO (1) WO2013105056A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2917742C (en) 2013-07-12 2020-04-14 Piramal Enterprises Limited A pharmaceutical combination for the treatment of melanoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331034B (en) 2002-07-08 2010-10-01 Piramal Life Sciences Ltd Inhibitors of cyclin-dependent kinases and their use
US7884127B2 (en) 2002-07-08 2011-02-08 Pirimal Life Sciences Ltd. Inhibitors of cyclin dependent kinases and their use
ES2491140T3 (es) 2006-06-21 2014-09-05 Piramal Enterprises Limited Derivados de flavona enantioméricamente puros para el tratamiento de trastornos proliferativos y procesos para su preparación
US7951961B2 (en) 2006-07-07 2011-05-31 Piramal Life Sciences Limited Enantioselective synthesis of pyrrolidines substituted with flavones, and intermediates thereof
TWI461194B (zh) * 2009-05-05 2014-11-21 Piramal Entpr Ltd 吡咯啶取代黃酮作為輻射致敏劑

Also Published As

Publication number Publication date
US20140348950A1 (en) 2014-11-27
EP2802323B1 (en) 2016-08-10
IN2014MN01546A (es) 2015-05-08
US20170071908A1 (en) 2017-03-16
TW201338774A (zh) 2013-10-01
WO2013105056A1 (en) 2013-07-18
EP2802323A1 (en) 2014-11-19

Similar Documents

Publication Publication Date Title
CL2018000318A1 (es) Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925)
CR20140223A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
CO6300939A2 (es) Compuestos novedosos que son inhibidores de erk referencia a una solicitud relacionada
CR20150472A (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
EA201650031A1 (ru) Производные пирролидин-2,5-диона, фармацевтические композиции и способы применения в качестве ингибиторов ido1
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
SV2010003767A (es) Compuestos pirazolicos 436
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
CR20110224A (es) Pirazolopirimidina inhibidor jak compuestos y metodos
NI200700320A (es) Inhibidores de la actividad akt
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
CR11099A (es) Uso de compuestos inhibidores de quinaxolina de p13k-alfa para el tratamiento del cancer
EA201590535A1 (ru) Способы лечения локально прогрессирующего запущенного рака молочной железы
UY32490A (es) Inhibidores de beta-secretasa
AR093759A1 (es) Dihidropiridona p1 como inhibidores del factor xia
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor
EA201692268A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
SV2009003389A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
CR20140135A (es) Nuevos derivados de aril-quinolina
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы

Legal Events

Date Code Title Description
FB Suspension of granting procedure